Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antiviral Agents | 46 | 2024 | 3060 | 4.040 |
Why?
|
Hepatitis C, Chronic | 26 | 2024 | 1032 | 3.700 |
Why?
|
Hepatitis B, Chronic | 16 | 2018 | 410 | 3.180 |
Why?
|
Elasticity Imaging Techniques | 10 | 2020 | 392 | 2.380 |
Why?
|
Hepatitis C | 23 | 2024 | 1584 | 2.050 |
Why?
|
Ribavirin | 16 | 2020 | 395 | 2.000 |
Why?
|
Liver Cirrhosis | 18 | 2020 | 1935 | 1.630 |
Why?
|
Benzimidazoles | 7 | 2024 | 858 | 1.620 |
Why?
|
Interferon-alpha | 20 | 2016 | 921 | 1.590 |
Why?
|
Hepacivirus | 26 | 2024 | 1336 | 1.440 |
Why?
|
Hepatitis B | 11 | 2019 | 705 | 1.340 |
Why?
|
Fatty Liver | 10 | 2018 | 790 | 1.280 |
Why?
|
Quinoxalines | 3 | 2023 | 296 | 1.270 |
Why?
|
Cholangitis, Sclerosing | 6 | 2021 | 177 | 1.240 |
Why?
|
Liver Transplantation | 22 | 2023 | 2330 | 1.240 |
Why?
|
Pyrrolidines | 2 | 2021 | 338 | 1.240 |
Why?
|
Carbamates | 3 | 2024 | 191 | 1.180 |
Why?
|
Hypertension, Portal | 5 | 2022 | 226 | 1.130 |
Why?
|
Lamivudine | 8 | 2016 | 366 | 1.110 |
Why?
|
Hepatitis B virus | 10 | 2019 | 528 | 1.080 |
Why?
|
Infectious Disease Transmission, Vertical | 11 | 2020 | 1351 | 1.050 |
Why?
|
Drug Combinations | 5 | 2024 | 2048 | 0.880 |
Why?
|
Sulfonamides | 4 | 2024 | 1978 | 0.830 |
Why?
|
Alanine Transaminase | 13 | 2021 | 603 | 0.770 |
Why?
|
Liver | 23 | 2020 | 7529 | 0.760 |
Why?
|
Child | 97 | 2024 | 80153 | 0.750 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2022 | 95 | 0.730 |
Why?
|
Polyethylene Glycols | 9 | 2016 | 1189 | 0.690 |
Why?
|
Pregnancy Complications, Infectious | 6 | 2020 | 2151 | 0.690 |
Why?
|
Child, Preschool | 55 | 2024 | 42230 | 0.630 |
Why?
|
Vascular Malformations | 1 | 2022 | 468 | 0.540 |
Why?
|
Adenine | 3 | 2012 | 987 | 0.530 |
Why?
|
Hepatitis B Vaccines | 6 | 2019 | 178 | 0.520 |
Why?
|
Adolescent | 75 | 2024 | 88319 | 0.510 |
Why?
|
Hepatitis B e Antigens | 5 | 2015 | 133 | 0.510 |
Why?
|
Guanine | 1 | 2015 | 279 | 0.470 |
Why?
|
Benzopyrans | 2 | 2024 | 63 | 0.450 |
Why?
|
Pregnant Women | 1 | 2018 | 566 | 0.440 |
Why?
|
Fluorenes | 3 | 2020 | 157 | 0.440 |
Why?
|
Bile Duct Diseases | 2 | 2007 | 97 | 0.430 |
Why?
|
Liver Diseases | 7 | 2020 | 1298 | 0.420 |
Why?
|
DNA, Viral | 8 | 2019 | 2202 | 0.410 |
Why?
|
Growth | 1 | 2014 | 365 | 0.410 |
Why?
|
Hepatitis B Surface Antigens | 7 | 2019 | 294 | 0.410 |
Why?
|
Hepatitis A | 2 | 2011 | 128 | 0.400 |
Why?
|
Infant | 35 | 2020 | 36192 | 0.400 |
Why?
|
Hepatitis, Viral, Human | 4 | 2004 | 141 | 0.390 |
Why?
|
Fissure in Ano | 2 | 2001 | 14 | 0.390 |
Why?
|
Hepatitis A Antibodies | 1 | 2011 | 19 | 0.380 |
Why?
|
Body Height | 3 | 2014 | 1570 | 0.370 |
Why?
|
Fontan Procedure | 2 | 2015 | 796 | 0.370 |
Why?
|
Cholestasis | 3 | 2007 | 378 | 0.350 |
Why?
|
Biopsy | 14 | 2020 | 6766 | 0.340 |
Why?
|
Female | 95 | 2024 | 392644 | 0.340 |
Why?
|
Humans | 152 | 2024 | 761504 | 0.330 |
Why?
|
Hemochromatosis | 3 | 2005 | 174 | 0.320 |
Why?
|
Recombinant Proteins | 15 | 2016 | 6534 | 0.310 |
Why?
|
Hepatitis C Antibodies | 5 | 2012 | 146 | 0.300 |
Why?
|
gamma-Glutamyltransferase | 4 | 2021 | 144 | 0.300 |
Why?
|
Male | 80 | 2024 | 360804 | 0.300 |
Why?
|
Colitis, Ulcerative | 2 | 2017 | 1922 | 0.290 |
Why?
|
Hepatitis, Autoimmune | 3 | 2015 | 172 | 0.290 |
Why?
|
Growth Disorders | 1 | 2012 | 655 | 0.280 |
Why?
|
Drug Therapy, Combination | 13 | 2024 | 6310 | 0.280 |
Why?
|
Liver Failure, Acute | 2 | 2006 | 181 | 0.270 |
Why?
|
Treatment Outcome | 26 | 2024 | 64680 | 0.270 |
Why?
|
Portal Vein | 4 | 2022 | 431 | 0.270 |
Why?
|
Cholestasis, Intrahepatic | 3 | 1997 | 75 | 0.250 |
Why?
|
Pediatrics | 2 | 2020 | 3589 | 0.250 |
Why?
|
Mass Screening | 4 | 2018 | 5428 | 0.250 |
Why?
|
Hepatopulmonary Syndrome | 1 | 2005 | 24 | 0.240 |
Why?
|
Biliary Atresia | 1 | 2005 | 88 | 0.240 |
Why?
|
Ursodeoxycholic Acid | 3 | 2021 | 81 | 0.230 |
Why?
|
Cystic Fibrosis | 4 | 2018 | 1285 | 0.230 |
Why?
|
Genotype | 9 | 2024 | 12990 | 0.230 |
Why?
|
Drug Resistance, Viral | 4 | 2018 | 862 | 0.220 |
Why?
|
Hepatitis | 2 | 2017 | 228 | 0.220 |
Why?
|
Body Composition | 2 | 2012 | 2426 | 0.220 |
Why?
|
Pregnancy | 12 | 2022 | 29874 | 0.220 |
Why?
|
Bilirubin | 3 | 2021 | 436 | 0.220 |
Why?
|
Hemodynamics | 1 | 2014 | 4159 | 0.220 |
Why?
|
ROC Curve | 3 | 2020 | 3579 | 0.210 |
Why?
|
Hypopituitarism | 1 | 2005 | 250 | 0.210 |
Why?
|
Predictive Value of Tests | 9 | 2018 | 15266 | 0.210 |
Why?
|
Early Diagnosis | 2 | 2020 | 1186 | 0.210 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 2 | 1995 | 141 | 0.200 |
Why?
|
Immunoglobulins, Intravenous | 5 | 2001 | 664 | 0.200 |
Why?
|
Esophageal and Gastric Varices | 2 | 2019 | 208 | 0.200 |
Why?
|
Ganciclovir | 1 | 2002 | 252 | 0.200 |
Why?
|
Viral Hepatitis Vaccines | 4 | 2004 | 72 | 0.200 |
Why?
|
Blood Transfusion | 2 | 2007 | 1298 | 0.200 |
Why?
|
Indicator Dilution Techniques | 2 | 1999 | 43 | 0.190 |
Why?
|
Diltiazem | 1 | 2001 | 131 | 0.190 |
Why?
|
Cutis Laxa | 1 | 2000 | 29 | 0.180 |
Why?
|
Heart Defects, Congenital | 2 | 2015 | 4671 | 0.180 |
Why?
|
Fibrosis | 3 | 2020 | 2049 | 0.180 |
Why?
|
Interferon Type I | 2 | 1996 | 562 | 0.170 |
Why?
|
Body Mass Index | 4 | 2015 | 12953 | 0.170 |
Why?
|
Disease Progression | 9 | 2021 | 13506 | 0.170 |
Why?
|
Infant, Newborn | 18 | 2018 | 26198 | 0.170 |
Why?
|
Biliary Tract Diseases | 2 | 2017 | 159 | 0.170 |
Why?
|
Hospitals, Pediatric | 3 | 2020 | 1860 | 0.170 |
Why?
|
Young Adult | 14 | 2019 | 59243 | 0.170 |
Why?
|
Maternal-Fetal Exchange | 2 | 2020 | 461 | 0.170 |
Why?
|
Boston | 6 | 2021 | 9326 | 0.160 |
Why?
|
Graves Disease | 1 | 2020 | 238 | 0.160 |
Why?
|
Hepatitis B Core Antigens | 3 | 2012 | 90 | 0.160 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2002 | 621 | 0.160 |
Why?
|
Uracil | 1 | 2020 | 207 | 0.160 |
Why?
|
Capsule Endoscopy | 1 | 2019 | 100 | 0.160 |
Why?
|
Child Welfare | 1 | 2003 | 521 | 0.160 |
Why?
|
Cardiac Output | 2 | 1999 | 831 | 0.160 |
Why?
|
Cyclopropanes | 1 | 2020 | 432 | 0.160 |
Why?
|
Lithium Chloride | 2 | 1999 | 82 | 0.160 |
Why?
|
Lactams, Macrocyclic | 1 | 2020 | 318 | 0.150 |
Why?
|
Proline | 1 | 2020 | 457 | 0.150 |
Why?
|
Uridine Monophosphate | 1 | 2018 | 68 | 0.150 |
Why?
|
Double-Blind Method | 5 | 2015 | 12341 | 0.150 |
Why?
|
Ritonavir | 1 | 2020 | 329 | 0.150 |
Why?
|
RNA, Viral | 8 | 2016 | 2846 | 0.150 |
Why?
|
Cat-Scratch Disease | 1 | 1997 | 23 | 0.150 |
Why?
|
Vancomycin | 1 | 2021 | 503 | 0.150 |
Why?
|
Immunologic Deficiency Syndromes | 3 | 2001 | 547 | 0.150 |
Why?
|
Hepatitis, Chronic | 3 | 2004 | 52 | 0.150 |
Why?
|
Graft Survival | 5 | 2021 | 3819 | 0.140 |
Why?
|
Extracorporeal Membrane Oxygenation | 3 | 1999 | 1462 | 0.140 |
Why?
|
Minocycline | 1 | 1998 | 169 | 0.140 |
Why?
|
Biliary Tract | 1 | 1998 | 135 | 0.140 |
Why?
|
Anilides | 1 | 2020 | 411 | 0.140 |
Why?
|
Ibuprofen | 1 | 1998 | 229 | 0.140 |
Why?
|
Pressure | 1 | 2020 | 1154 | 0.140 |
Why?
|
Choledochostomy | 1 | 2016 | 16 | 0.140 |
Why?
|
Follow-Up Studies | 13 | 2020 | 39106 | 0.130 |
Why?
|
Cytomegalovirus Infections | 1 | 2002 | 831 | 0.130 |
Why?
|
Drug Administration Schedule | 4 | 2017 | 4853 | 0.130 |
Why?
|
Liver Function Tests | 4 | 2019 | 523 | 0.130 |
Why?
|
Stevens-Johnson Syndrome | 1 | 1998 | 246 | 0.130 |
Why?
|
Carcinoma, Hepatocellular | 5 | 2019 | 2298 | 0.130 |
Why?
|
Hyalin | 1 | 2015 | 34 | 0.130 |
Why?
|
Common Variable Immunodeficiency | 1 | 1996 | 101 | 0.120 |
Why?
|
Retrospective Studies | 21 | 2023 | 80636 | 0.120 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 1995 | 247 | 0.120 |
Why?
|
Immunization | 1 | 2019 | 1228 | 0.120 |
Why?
|
Carrier State | 2 | 1990 | 523 | 0.120 |
Why?
|
Prevalence | 8 | 2018 | 15732 | 0.120 |
Why?
|
Kupffer Cells | 1 | 2015 | 143 | 0.120 |
Why?
|
Urban Health | 1 | 1997 | 532 | 0.120 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2019 | 1116 | 0.120 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 1996 | 233 | 0.120 |
Why?
|
Adult | 29 | 2024 | 221177 | 0.110 |
Why?
|
Tacrolimus | 3 | 2016 | 733 | 0.110 |
Why?
|
Cohort Studies | 9 | 2018 | 41487 | 0.110 |
Why?
|
Obesity | 3 | 2013 | 12947 | 0.110 |
Why?
|
Transplantation, Homologous | 2 | 2020 | 4806 | 0.110 |
Why?
|
Living Donors | 1 | 1998 | 641 | 0.110 |
Why?
|
Adolescent Health Services | 2 | 2007 | 218 | 0.110 |
Why?
|
Liver Neoplasms | 6 | 2019 | 4320 | 0.110 |
Why?
|
Organ Transplantation | 2 | 2021 | 1157 | 0.110 |
Why?
|
Portasystemic Shunt, Surgical | 2 | 2005 | 39 | 0.100 |
Why?
|
Hemodialysis Units, Hospital | 1 | 1992 | 22 | 0.100 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 1994 | 147 | 0.100 |
Why?
|
Liver Failure | 4 | 2012 | 250 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2017 | 10766 | 0.100 |
Why?
|
Diarrhea, Infantile | 1 | 1991 | 100 | 0.100 |
Why?
|
Dyslipidemias | 1 | 2019 | 868 | 0.090 |
Why?
|
Hepatoblastoma | 2 | 2010 | 90 | 0.090 |
Why?
|
Lectins | 1 | 2013 | 491 | 0.090 |
Why?
|
Risk Factors | 12 | 2023 | 74206 | 0.090 |
Why?
|
Adipokines | 1 | 2013 | 310 | 0.090 |
Why?
|
Risk Adjustment | 1 | 2015 | 600 | 0.090 |
Why?
|
Diet, Fat-Restricted | 1 | 2013 | 329 | 0.090 |
Why?
|
Glomerulonephritis, Membranous | 1 | 1991 | 88 | 0.090 |
Why?
|
Immunization Schedule | 2 | 2003 | 227 | 0.090 |
Why?
|
Primary Health Care | 1 | 2007 | 4686 | 0.090 |
Why?
|
Graft Rejection | 3 | 2021 | 4445 | 0.090 |
Why?
|
Acute Disease | 3 | 2015 | 7237 | 0.080 |
Why?
|
Hyaluronic Acid | 1 | 2013 | 483 | 0.080 |
Why?
|
Quality Improvement | 2 | 2023 | 3801 | 0.080 |
Why?
|
Registries | 3 | 2021 | 8224 | 0.080 |
Why?
|
Biopsy, Needle | 2 | 2013 | 1626 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2014 | 12059 | 0.080 |
Why?
|
Prospective Studies | 9 | 2020 | 54425 | 0.080 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 8002 | 0.080 |
Why?
|
Area Under Curve | 1 | 2013 | 1638 | 0.080 |
Why?
|
Adiponectin | 1 | 2015 | 1113 | 0.080 |
Why?
|
Propylthiouracil | 1 | 1988 | 68 | 0.080 |
Why?
|
Viremia | 3 | 2016 | 707 | 0.080 |
Why?
|
Aspartate Aminotransferases | 2 | 2021 | 416 | 0.080 |
Why?
|
Intestinal Pseudo-Obstruction | 1 | 1988 | 49 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3882 | 0.080 |
Why?
|
Behavior | 1 | 2011 | 541 | 0.080 |
Why?
|
Decision Trees | 1 | 2020 | 504 | 0.070 |
Why?
|
Disease Transmission, Infectious | 2 | 2007 | 559 | 0.070 |
Why?
|
Digestive System Neoplasms | 1 | 2008 | 82 | 0.070 |
Why?
|
Severity of Illness Index | 4 | 2020 | 15842 | 0.070 |
Why?
|
Placebos | 1 | 2012 | 1667 | 0.070 |
Why?
|
Administration, Oral | 3 | 2021 | 4021 | 0.070 |
Why?
|
Drug Contamination | 3 | 2001 | 152 | 0.070 |
Why?
|
Serum Albumin | 2 | 2021 | 672 | 0.070 |
Why?
|
Thalassemia | 1 | 2008 | 267 | 0.070 |
Why?
|
Biliary Tract Surgical Procedures | 1 | 2007 | 45 | 0.070 |
Why?
|
Chromosome Mapping | 1 | 1995 | 4615 | 0.070 |
Why?
|
Deferoxamine | 1 | 1987 | 155 | 0.070 |
Why?
|
Alagille Syndrome | 1 | 2007 | 45 | 0.070 |
Why?
|
Rifamycins | 1 | 2006 | 26 | 0.070 |
Why?
|
Lactulose | 1 | 2006 | 31 | 0.070 |
Why?
|
Interferons | 2 | 2001 | 706 | 0.070 |
Why?
|
Vena Cava, Inferior | 1 | 2010 | 458 | 0.070 |
Why?
|
Autoantibodies | 2 | 2013 | 2116 | 0.070 |
Why?
|
Drug Tolerance | 1 | 2008 | 367 | 0.070 |
Why?
|
Time Factors | 6 | 2021 | 39967 | 0.070 |
Why?
|
Research Design | 1 | 2002 | 6180 | 0.070 |
Why?
|
Gene Products, pol | 1 | 2006 | 43 | 0.070 |
Why?
|
Animal Population Groups | 1 | 1985 | 12 | 0.070 |
Why?
|
Galactosidases | 1 | 1985 | 55 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2020 | 2947 | 0.060 |
Why?
|
Animals, Suckling | 1 | 1985 | 69 | 0.060 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2005 | 49 | 0.060 |
Why?
|
Hepatic Encephalopathy | 1 | 2006 | 144 | 0.060 |
Why?
|
Eating | 1 | 2012 | 1539 | 0.060 |
Why?
|
Ultrasonography, Interventional | 1 | 2013 | 1496 | 0.060 |
Why?
|
Ileum | 1 | 2007 | 557 | 0.060 |
Why?
|
Scleroderma, Systemic | 1 | 1988 | 344 | 0.060 |
Why?
|
Heart | 1 | 1998 | 4404 | 0.060 |
Why?
|
Recurrence | 3 | 2021 | 8465 | 0.060 |
Why?
|
Seroepidemiologic Studies | 2 | 2019 | 397 | 0.060 |
Why?
|
beta-Galactosidase | 1 | 1985 | 574 | 0.060 |
Why?
|
Crohn Disease | 1 | 2017 | 2279 | 0.060 |
Why?
|
Cross-Sectional Studies | 5 | 2018 | 26125 | 0.060 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2007 | 450 | 0.060 |
Why?
|
Stents | 1 | 2016 | 3179 | 0.060 |
Why?
|
Postoperative Complications | 4 | 2016 | 15631 | 0.060 |
Why?
|
Longitudinal Studies | 3 | 2016 | 14605 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 1999 | 3627 | 0.060 |
Why?
|
Muscular Diseases | 1 | 1988 | 553 | 0.060 |
Why?
|
Iron | 3 | 2008 | 1793 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3245 | 0.060 |
Why?
|
Linear Models | 1 | 2014 | 5871 | 0.060 |
Why?
|
Hepatitis B Antibodies | 1 | 2004 | 155 | 0.060 |
Why?
|
Body Weight | 2 | 2012 | 4618 | 0.060 |
Why?
|
Child Behavior | 1 | 2009 | 847 | 0.050 |
Why?
|
Amlodipine | 1 | 2023 | 84 | 0.050 |
Why?
|
Cognition | 2 | 2011 | 6990 | 0.050 |
Why?
|
Serologic Tests | 2 | 1998 | 381 | 0.050 |
Why?
|
Age Factors | 4 | 2021 | 18395 | 0.050 |
Why?
|
Lipids | 1 | 2013 | 3341 | 0.050 |
Why?
|
Gastrointestinal Agents | 1 | 2006 | 510 | 0.050 |
Why?
|
Morbidity | 1 | 2007 | 1750 | 0.050 |
Why?
|
Weight Loss | 1 | 2013 | 2684 | 0.050 |
Why?
|
Insulin Resistance | 2 | 2013 | 3963 | 0.050 |
Why?
|
Prognosis | 6 | 2020 | 29625 | 0.050 |
Why?
|
Neutropenia | 2 | 2010 | 885 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2008 | 9177 | 0.050 |
Why?
|
Immunoglobulin G | 2 | 2015 | 4544 | 0.050 |
Why?
|
Egypt | 1 | 2020 | 97 | 0.050 |
Why?
|
Intestines | 2 | 1991 | 1909 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2007 | 4111 | 0.050 |
Why?
|
Florida | 2 | 2012 | 431 | 0.050 |
Why?
|
2-Naphthylamine | 1 | 2020 | 20 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14666 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2244 | 0.050 |
Why?
|
Cholangiography | 1 | 2020 | 181 | 0.040 |
Why?
|
Causality | 1 | 2007 | 1242 | 0.040 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1989 | 2199 | 0.040 |
Why?
|
Glycoproteins | 1 | 2008 | 2203 | 0.040 |
Why?
|
Breast Feeding | 1 | 2009 | 1359 | 0.040 |
Why?
|
Inflammation | 1 | 2020 | 10773 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 1998 | 7407 | 0.040 |
Why?
|
Digestive System | 1 | 2000 | 244 | 0.040 |
Why?
|
Tablets | 1 | 2020 | 148 | 0.040 |
Why?
|
Vaccination | 2 | 2009 | 3384 | 0.040 |
Why?
|
Thrombosis | 2 | 2010 | 2942 | 0.040 |
Why?
|
Administration, Topical | 1 | 2001 | 704 | 0.040 |
Why?
|
United States | 8 | 2021 | 72334 | 0.040 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2019 | 33 | 0.040 |
Why?
|
Incidence | 4 | 2013 | 21353 | 0.040 |
Why?
|
Emotions | 1 | 2011 | 2739 | 0.040 |
Why?
|
Penicillamine | 1 | 1998 | 60 | 0.040 |
Why?
|
Sample Size | 1 | 2002 | 841 | 0.040 |
Why?
|
Manometry | 1 | 2001 | 454 | 0.040 |
Why?
|
Anorexia Nervosa | 1 | 2008 | 1361 | 0.040 |
Why?
|
Phenotype | 1 | 2016 | 16591 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10209 | 0.040 |
Why?
|
Blood Glucose | 1 | 2013 | 6391 | 0.040 |
Why?
|
Hepatolenticular Degeneration | 1 | 1998 | 72 | 0.040 |
Why?
|
Urethra | 1 | 2000 | 405 | 0.040 |
Why?
|
Chorion | 1 | 1998 | 114 | 0.040 |
Why?
|
Valine | 1 | 2020 | 408 | 0.040 |
Why?
|
Patient Selection | 1 | 2010 | 4244 | 0.040 |
Why?
|
Quality of Life | 2 | 2011 | 13367 | 0.040 |
Why?
|
Survival Analysis | 3 | 2008 | 10090 | 0.040 |
Why?
|
Anal Canal | 1 | 2001 | 373 | 0.040 |
Why?
|
Blood Group Incompatibility | 1 | 1999 | 135 | 0.040 |
Why?
|
Massachusetts | 3 | 2015 | 8830 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 781 | 0.040 |
Why?
|
Random Allocation | 1 | 2002 | 2395 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9280 | 0.040 |
Why?
|
Harm Reduction | 1 | 2019 | 144 | 0.040 |
Why?
|
Kidney | 3 | 2023 | 7048 | 0.040 |
Why?
|
Streptococcus | 1 | 1997 | 198 | 0.040 |
Why?
|
Amnion | 1 | 1998 | 197 | 0.040 |
Why?
|
Galactosemias | 1 | 1998 | 124 | 0.040 |
Why?
|
Hip Fractures | 1 | 2005 | 988 | 0.040 |
Why?
|
Chronic Disease | 3 | 2001 | 9318 | 0.040 |
Why?
|
Chelating Agents | 1 | 1998 | 387 | 0.040 |
Why?
|
Thyroxine | 1 | 2020 | 666 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1991 | 3415 | 0.030 |
Why?
|
Burkholderia cepacia | 1 | 1996 | 22 | 0.030 |
Why?
|
Streptococcus agalactiae | 1 | 1998 | 337 | 0.030 |
Why?
|
Caregivers | 1 | 2009 | 2237 | 0.030 |
Why?
|
Hepatitis D | 1 | 1996 | 23 | 0.030 |
Why?
|
ABO Blood-Group System | 1 | 1999 | 380 | 0.030 |
Why?
|
Hepatitis B Antigens | 1 | 2015 | 38 | 0.030 |
Why?
|
Peptides | 1 | 2008 | 4358 | 0.030 |
Why?
|
Venous Thrombosis | 1 | 2005 | 1303 | 0.030 |
Why?
|
Internationality | 1 | 2021 | 1001 | 0.030 |
Why?
|
Intestinal Mucosa | 2 | 2001 | 3032 | 0.030 |
Why?
|
Models, Statistical | 1 | 2010 | 5079 | 0.030 |
Why?
|
Microscopy, Electron | 4 | 2001 | 2561 | 0.030 |
Why?
|
Drug Resistance | 1 | 2021 | 1596 | 0.030 |
Why?
|
Streptococcus pyogenes | 1 | 1998 | 292 | 0.030 |
Why?
|
Blood Component Transfusion | 1 | 1996 | 142 | 0.030 |
Why?
|
Metabolism, Inborn Errors | 1 | 1997 | 284 | 0.030 |
Why?
|
Oxidoreductases | 1 | 1997 | 413 | 0.030 |
Why?
|
Bile Acids and Salts | 1 | 1997 | 393 | 0.030 |
Why?
|
Thyroidectomy | 1 | 2020 | 907 | 0.030 |
Why?
|
Isoniazid | 1 | 1996 | 283 | 0.030 |
Why?
|
Risk Assessment | 4 | 2017 | 23995 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2010 | 4234 | 0.030 |
Why?
|
Mitochondrial Proteins | 1 | 2020 | 976 | 0.030 |
Why?
|
Nephrotic Syndrome | 1 | 1998 | 390 | 0.030 |
Why?
|
Tissue Donors | 2 | 2016 | 2331 | 0.030 |
Why?
|
Liver Regeneration | 1 | 1996 | 213 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2023 | 2176 | 0.030 |
Why?
|
Urinary Bladder | 1 | 2000 | 1152 | 0.030 |
Why?
|
Bile Ducts | 2 | 2010 | 282 | 0.030 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7390 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2000 | 1302 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 1998 | 1371 | 0.030 |
Why?
|
School Health Services | 1 | 1997 | 384 | 0.030 |
Why?
|
Inclusion Bodies | 1 | 2015 | 281 | 0.030 |
Why?
|
Keratinocytes | 1 | 1998 | 790 | 0.030 |
Why?
|
Prednisone | 1 | 1998 | 1563 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2009 | 4481 | 0.030 |
Why?
|
Giant Cells | 1 | 1994 | 188 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1913 | 0.030 |
Why?
|
Acne Vulgaris | 1 | 1998 | 358 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2001 | 2416 | 0.030 |
Why?
|
Middle Aged | 10 | 2015 | 220895 | 0.030 |
Why?
|
Respiratory System | 1 | 1996 | 563 | 0.030 |
Why?
|
Drug Resistance, Multiple, Viral | 1 | 2013 | 53 | 0.030 |
Why?
|
Kidney Diseases, Cystic | 1 | 1994 | 183 | 0.030 |
Why?
|
Microcirculation | 1 | 1997 | 1273 | 0.030 |
Why?
|
Hepatectomy | 1 | 1996 | 557 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 1 | 1997 | 529 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 1998 | 2850 | 0.030 |
Why?
|
Hepatitis Antibodies | 1 | 1992 | 67 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 1998 | 981 | 0.030 |
Why?
|
Infectious Disease Medicine | 1 | 2012 | 49 | 0.020 |
Why?
|
Splenic Vein | 1 | 1991 | 30 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2021 | 2161 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12974 | 0.020 |
Why?
|
Risk-Taking | 1 | 1997 | 1038 | 0.020 |
Why?
|
Spleen | 1 | 1997 | 2295 | 0.020 |
Why?
|
Immunosuppressive Agents | 2 | 2016 | 4174 | 0.020 |
Why?
|
Sexually Transmitted Diseases | 1 | 1997 | 662 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 1998 | 36426 | 0.020 |
Why?
|
Pain Measurement | 1 | 2001 | 3550 | 0.020 |
Why?
|
Nutrition Disorders | 1 | 1991 | 205 | 0.020 |
Why?
|
Subcutaneous Emphysema | 1 | 1990 | 15 | 0.020 |
Why?
|
Glycemic Index | 1 | 2013 | 396 | 0.020 |
Why?
|
Pneumatosis Cystoides Intestinalis | 1 | 1990 | 31 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 1996 | 6075 | 0.020 |
Why?
|
Wound Healing | 1 | 2001 | 2805 | 0.020 |
Why?
|
Counseling | 1 | 2018 | 1547 | 0.020 |
Why?
|
Hospitalization | 2 | 2006 | 10723 | 0.020 |
Why?
|
Diet, Reducing | 1 | 2013 | 485 | 0.020 |
Why?
|
Logistic Models | 2 | 2002 | 13255 | 0.020 |
Why?
|
AIDS-Related Complex | 1 | 1989 | 107 | 0.020 |
Why?
|
Haplotypes | 1 | 1995 | 2713 | 0.020 |
Why?
|
Algorithms | 1 | 2020 | 14031 | 0.020 |
Why?
|
Catheters, Indwelling | 1 | 1991 | 426 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1996 | 3810 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 4 | 2010 | 20570 | 0.020 |
Why?
|
Cysts | 1 | 1994 | 681 | 0.020 |
Why?
|
Fatal Outcome | 1 | 1994 | 1834 | 0.020 |
Why?
|
Legal Guardians | 1 | 2009 | 57 | 0.020 |
Why?
|
Brain Death | 1 | 2012 | 357 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5247 | 0.020 |
Why?
|
Adolescent Behavior | 1 | 1997 | 1190 | 0.020 |
Why?
|
Escherichia coli | 1 | 2001 | 4217 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11076 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 2013 | 891 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2001 | 3396 | 0.020 |
Why?
|
Antibodies | 1 | 1996 | 2418 | 0.020 |
Why?
|
Viral Load | 1 | 2017 | 3332 | 0.020 |
Why?
|
Antitubercular Agents | 1 | 1996 | 1375 | 0.020 |
Why?
|
Intra-Abdominal Fat | 1 | 2013 | 613 | 0.020 |
Why?
|
Mothers | 1 | 2018 | 2198 | 0.020 |
Why?
|
Sickness Impact Profile | 1 | 2009 | 299 | 0.020 |
Why?
|
Emphysema | 1 | 1990 | 238 | 0.020 |
Why?
|
Intestinal Diseases | 1 | 2012 | 504 | 0.020 |
Why?
|
Immunization, Passive | 1 | 1990 | 616 | 0.020 |
Why?
|
Sexual Behavior | 1 | 1997 | 2180 | 0.020 |
Why?
|
Ultrasonography | 1 | 2000 | 5972 | 0.020 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2007 | 61 | 0.020 |
Why?
|
Sweat | 1 | 2007 | 56 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1998 | 4352 | 0.020 |
Why?
|
Hybridomas | 1 | 2008 | 442 | 0.020 |
Why?
|
Isoproterenol | 1 | 2007 | 395 | 0.020 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2007 | 100 | 0.020 |
Why?
|
Pneumonia | 1 | 1998 | 2143 | 0.020 |
Why?
|
Bacterial Adhesion | 2 | 1998 | 306 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2422 | 0.020 |
Why?
|
Ion Transport | 1 | 2007 | 319 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 1996 | 1749 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2010 | 683 | 0.020 |
Why?
|
Splenorenal Shunt, Surgical | 1 | 2005 | 14 | 0.020 |
Why?
|
Intestine, Small | 1 | 2012 | 1206 | 0.020 |
Why?
|
Colon | 1 | 1994 | 1792 | 0.020 |
Why?
|
Sucrase | 1 | 1985 | 51 | 0.020 |
Why?
|
Health Behavior | 1 | 1997 | 2643 | 0.020 |
Why?
|
Blood Pressure | 1 | 2001 | 8481 | 0.020 |
Why?
|
Cells, Cultured | 4 | 2008 | 18965 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 1997 | 4431 | 0.020 |
Why?
|
Weaning | 1 | 1985 | 103 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2008 | 13639 | 0.020 |
Why?
|
Microvilli | 1 | 1985 | 234 | 0.020 |
Why?
|
Tritium | 1 | 1985 | 708 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2012 | 1733 | 0.020 |
Why?
|
Heart Diseases | 1 | 1998 | 2781 | 0.010 |
Why?
|
Pancreas | 1 | 1991 | 1691 | 0.010 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2007 | 506 | 0.010 |
Why?
|
Alleles | 1 | 1995 | 6863 | 0.010 |
Why?
|
Sampling Studies | 1 | 2005 | 615 | 0.010 |
Why?
|
Leucine | 1 | 1985 | 548 | 0.010 |
Why?
|
Tissue and Organ Procurement | 1 | 2012 | 961 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2020 | 7856 | 0.010 |
Why?
|
Safety | 1 | 2008 | 1150 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 2005 | 462 | 0.010 |
Why?
|
Germany | 1 | 2005 | 875 | 0.010 |
Why?
|
Adiposity | 1 | 2013 | 1878 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 1741 | 0.010 |
Why?
|
Epithelium | 2 | 1998 | 1603 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2005 | 58976 | 0.010 |
Why?
|
Probability | 1 | 2008 | 2477 | 0.010 |
Why?
|
Environmental Exposure | 1 | 1997 | 4486 | 0.010 |
Why?
|
Reoperation | 2 | 1993 | 4303 | 0.010 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2004 | 295 | 0.010 |
Why?
|
Aorta | 1 | 2010 | 2042 | 0.010 |
Why?
|
Health Surveys | 1 | 2012 | 4061 | 0.010 |
Why?
|
Computer Simulation | 1 | 1995 | 6240 | 0.010 |
Why?
|
Cytochalasin D | 1 | 2001 | 91 | 0.010 |
Why?
|
Hepatocytes | 1 | 2008 | 1233 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2006 | 1668 | 0.010 |
Why?
|
Risk | 2 | 1996 | 9610 | 0.010 |
Why?
|
Annexin A5 | 1 | 2001 | 103 | 0.010 |
Why?
|
Canada | 1 | 2006 | 2122 | 0.010 |
Why?
|
Colony-Forming Units Assay | 1 | 2001 | 352 | 0.010 |
Why?
|
Sex Distribution | 1 | 2005 | 2281 | 0.010 |
Why?
|
Myeloid Progenitor Cells | 1 | 2001 | 113 | 0.010 |
Why?
|
Angiography | 1 | 2005 | 1595 | 0.010 |
Why?
|
Caco-2 Cells | 1 | 2001 | 364 | 0.010 |
Why?
|
Needs Assessment | 1 | 2006 | 1139 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2880 | 0.010 |
Why?
|
Patient Compliance | 1 | 1990 | 2690 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1998 | 20098 | 0.010 |
Why?
|
Nutritional Status | 1 | 2008 | 1615 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 1992 | 2471 | 0.010 |
Why?
|
Periodicity | 1 | 2001 | 348 | 0.010 |
Why?
|
Micromonosporaceae | 1 | 1998 | 1 | 0.010 |
Why?
|
Colchicine | 1 | 2001 | 259 | 0.010 |
Why?
|
Trientine | 1 | 1998 | 12 | 0.010 |
Why?
|
Apolipoproteins C | 1 | 1998 | 59 | 0.010 |
Why?
|
Public Health | 1 | 2012 | 2669 | 0.010 |
Why?
|
Family | 1 | 1990 | 3194 | 0.010 |
Why?
|
Apoptosis | 2 | 2008 | 9486 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 2001 | 658 | 0.010 |
Why?
|
Hemosiderosis | 1 | 1998 | 66 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1985 | 2113 | 0.010 |
Why?
|
Spectrometry, Mass, Fast Atom Bombardment | 1 | 1997 | 33 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2001 | 629 | 0.010 |
Why?
|
Culture Techniques | 1 | 1998 | 531 | 0.010 |
Why?
|
Cholic Acids | 1 | 1997 | 39 | 0.010 |
Why?
|
Cholic Acid | 1 | 1997 | 31 | 0.010 |
Why?
|
Aged | 5 | 2005 | 169289 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2008 | 1459 | 0.010 |
Why?
|
Lymphocytosis | 1 | 1998 | 121 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2008 | 6814 | 0.010 |
Why?
|
Antigens, CD | 1 | 2008 | 4003 | 0.010 |
Why?
|
Gastroenterology | 1 | 2004 | 577 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 6484 | 0.010 |
Why?
|
Sepsis | 1 | 1991 | 2585 | 0.010 |
Why?
|
Radiography | 1 | 1988 | 6965 | 0.010 |
Why?
|
Galactose | 1 | 1998 | 297 | 0.010 |
Why?
|
Retreatment | 1 | 1998 | 598 | 0.010 |
Why?
|
Neutrophils | 2 | 2001 | 3767 | 0.010 |
Why?
|
Administration, Intranasal | 1 | 1998 | 477 | 0.010 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 1997 | 353 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1998 | 280 | 0.010 |
Why?
|
Models, Biological | 1 | 1993 | 9469 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2009 | 3600 | 0.010 |
Why?
|
Burkholderia Infections | 1 | 1996 | 41 | 0.010 |
Why?
|
Survival Rate | 2 | 2005 | 12725 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 1998 | 585 | 0.010 |
Why?
|
Family Health | 1 | 2001 | 1257 | 0.010 |
Why?
|
Research | 1 | 2004 | 1982 | 0.010 |
Why?
|
Microtubules | 1 | 2001 | 1074 | 0.010 |
Why?
|
Parents | 1 | 2009 | 3563 | 0.010 |
Why?
|
Caroli Disease | 1 | 1994 | 12 | 0.010 |
Why?
|
Cell Line | 2 | 2001 | 15601 | 0.010 |
Why?
|
Polycystic Kidney, Autosomal Recessive | 1 | 1994 | 31 | 0.010 |
Why?
|
Rifampin | 1 | 1996 | 339 | 0.010 |
Why?
|
New York City | 1 | 1996 | 731 | 0.010 |
Why?
|
Biological Transport | 1 | 1998 | 2091 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1996 | 1705 | 0.010 |
Why?
|
Pilot Projects | 1 | 2006 | 8631 | 0.010 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 1994 | 166 | 0.010 |
Why?
|
Cell Division | 1 | 2001 | 4465 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2001 | 1667 | 0.010 |
Why?
|
Lidocaine | 1 | 1996 | 538 | 0.010 |
Why?
|
Antigens, Bacterial | 1 | 1998 | 1155 | 0.010 |
Why?
|
Health Status | 1 | 2006 | 4077 | 0.010 |
Why?
|
Length of Stay | 1 | 2006 | 6425 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2008 | 10445 | 0.010 |
Why?
|
Societies, Medical | 1 | 2004 | 3905 | 0.010 |
Why?
|
Mathematics | 1 | 1993 | 707 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 16981 | 0.010 |
Why?
|
Cytoskeleton | 1 | 1996 | 1170 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2001 | 2049 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 1998 | 2206 | 0.010 |
Why?
|
Cell Survival | 1 | 2001 | 5791 | 0.010 |
Why?
|
Lymphocytes | 1 | 1998 | 2612 | 0.010 |
Why?
|
Databases, Factual | 1 | 2006 | 7967 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5368 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 1998 | 3734 | 0.010 |
Why?
|
New England | 1 | 1993 | 1054 | 0.010 |
Why?
|
Splenectomy | 1 | 1991 | 391 | 0.010 |
Why?
|
Rats | 1 | 1985 | 23742 | 0.010 |
Why?
|
Animals | 4 | 2001 | 168459 | 0.000 |
Why?
|
Chemotherapy, Adjuvant | 1 | 1996 | 3514 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1998 | 5789 | 0.000 |
Why?
|
Stomach | 1 | 1991 | 696 | 0.000 |
Why?
|
Mice, Transgenic | 1 | 1998 | 9539 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1996 | 8529 | 0.000 |
Why?
|
Mice, Knockout | 1 | 1998 | 14414 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1998 | 11528 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1998 | 22169 | 0.000 |
Why?
|
Lung | 1 | 1998 | 10000 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1994 | 18252 | 0.000 |
Why?
|
Mice | 1 | 1998 | 81525 | 0.000 |
Why?
|
Brain | 1 | 1997 | 27112 | 0.000 |
Why?
|